CDC: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women
Background: Overdose deaths have increased steadily over the past decade. This report describes drug-related deaths and emergency department (ED) visits among women.
Advertisement for curing morphine addictions from Overland Monthly, January 1900. Wikipedia
Methods: CDC analyzed rates of fatal drug overdoses and drug misuse- or abuse-related ED visits among women using data from the National Vital Statistics System (1999–2010) and the Drug Abuse Warning Network (2004–2010).
Results: In 2010, a total of 15,323 deaths among women were attributed to drug overdose, a rate of 9.8 per 100,000 population. Deaths from opioid pain relievers (OPRs) increased fivefold between 1999 and 2010 for women; OPR deaths among men increased 3.6 times. In 2010, there were 943,365 ED visits by women for drug misuse or abuse. The highest ED visit rates were for cocaine or heroin (147.2 per 100,000 population), benzodiazepines (134.6), and OPR (129.6). ED visits related to misuse or abuse of OPR among women more than doubled between 2004 and 2010.
Conclusions: Although more men die from drug overdoses than women, the percentage increase in deaths since 1999 is greater among women. More women have died each year from drug overdoses than from motor vehicle–related injuries since 2007. Deaths and ED visits related to OPR continue to increase among women. The prominent involvement of psychotherapeutic drugs, such as benzodiazepines, among overdoses provides insight for prevention opportunities.
Implications for Public Health Practice: Health-care providers should follow guidelines for responsible prescribing, including screening and monitoring for substance abuse and mental health problems, when prescribing OPR. Health-care providers who treat women for pain should use their state's prescription drug monitoring program and regularly screen patients for psychological disorders and use of psychotherapeutic drugs, with or without a prescription.
In 2010, enough opioid pain relievers (OPR) were sold to medicate every adult in the United States with the equivalent of a typical dose of 5 mg of hydrocodone every 4 hours for 1 month (1), a 300% increase in the sales rate over 11 years. This rise in distribution of OPR is concomitant with increasing rates of drug overdose death and chronic, nonmedical use of OPR (2,3).
Pages: 1 · 2
- Is the Queen Bee Lack of Effectiveness In 'Availability' to Blame? Bee Informed Partnership Releases Another Discouraging Report About Bee Colony Loss
- Testing a Hypothesis: Poor Sleep Could Be an Early Warning Sign or Biomarker of Alzheimer's
- NCI-MATCH Precision MedicineTrial: Determining whether targeted therapies for people whose tumors have specific gene mutations will be effective regardless of their cancer type
- Bring Along the Sunscreen For That Sun-bathing Weekend: Cancer-associated DNA Changes Exist in 25% of Normal Skin Cells
- Streaming on May 10th: NCCIH Presents When Experts Disagree, The Art of Medical Decision Making
- Regulating Millions of Cosmetic Products Sold: Supporting The Personal Care Products Safety Act Proposal
- An Imprint on Your Health: Heart attack Risk High in Divorced Women, Even After Remarrying
- Using the Drug: Women Twice as Likely to See Pot as Risky
- More States Demand Notification to Use Biosimilar Drugs
- A Look Back at Julia Sneden's Review of The Emperor of All Maladies